Global Next-Generation Sequencing (NGS) Services Market Size, Share, Trends and Forecast 2022-2030

Description

Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.
Industry Insights

The global Next-Generation Sequencing (NGS) Services market size is projected to reach US$ 10170 million by 2028, from US$ 3690.2 million in 2021, at a CAGR of 15.4% during 2022-2028.

The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.

Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.

North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.

Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Next-Generation Sequencing (NGS) Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Next-Generation Sequencing (NGS) Services market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Next-Generation Sequencing (NGS) Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Next-Generation Sequencing (NGS) Services market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Next-Generation Sequencing (NGS) Services market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Next-Generation Sequencing (NGS) Services Breakdown Data by Type

Targeted Sequencing

Whole Exome Sequencing

Whole Genome Sequencing

Next-Generation Sequencing (NGS) Services Breakdown Data by Application

Hospitals and Clinics

Biopharma Companies

Academic & Research Organizations

Others

Regional Analysis

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Eurofins Scientific

Natera

BGI

Illumina

Roche

LabCorp

Berry Genomics

Brooks Life Sciences

Macrogen

Personalis

Novogene

Genotypic Technology

Dna Link

TABLE OF CONTENT

1 Report Overview
1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Next-Generation Sequencing (NGS) Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Targeted Sequencing

1.2.3 Whole Exome Sequencing

1.2.4 Whole Genome Sequencing

1.3 Market by Application

1.3.1 Global Next-Generation Sequencing (NGS) Services Market Share by Application: 2017 VS 2021 VS 2028

1.3.2 Hospitals and Clinics

1.3.3 Biopharma Companies

1.3.4 Academic & Research Organizations

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Next-Generation Sequencing (NGS) Services Market Perspective (2017-2028)

2.2 Next-Generation Sequencing (NGS) Services Growth Trends by Region

2.2.1 Next-Generation Sequencing (NGS) Services Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Next-Generation Sequencing (NGS) Services Historic Market Size by Region (2017-2022)

2.2.3 Next-Generation Sequencing (NGS) Services Forecasted Market Size by Region (2023-2028)

2.3 Next-Generation Sequencing (NGS) Services Market Dynamics

2.3.1 Next-Generation Sequencing (NGS) Services Industry Trends

2.3.2 Next-Generation Sequencing (NGS) Services Market Drivers

2.3.3 Next-Generation Sequencing (NGS) Services Market Challenges

2.3.4 Next-Generation Sequencing (NGS) Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Next-Generation Sequencing (NGS) Services Players by Revenue

3.1.1 Global Top Next-Generation Sequencing (NGS) Services Players by Revenue (2017-2022)

3.1.2 Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Players (2017-2022)

3.2 Global Next-Generation Sequencing (NGS) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Next-Generation Sequencing (NGS) Services Revenue

3.4 Global Next-Generation Sequencing (NGS) Services Market Concentration Ratio

3.4.1 Global Next-Generation Sequencing (NGS) Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Sequencing (NGS) Services Revenue in 2021

3.5 Next-Generation Sequencing (NGS) Services Key Players Head office and Area Served

3.6 Key Players Next-Generation Sequencing (NGS) Services Product Solution and Service

3.7 Date of Enter into Next-Generation Sequencing (NGS) Services Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Next-Generation Sequencing (NGS) Services Breakdown Data by Type

4.1 Global Next-Generation Sequencing (NGS) Services Historic Market Size by Type (2017-2022)

4.2 Global Next-Generation Sequencing (NGS) Services Forecasted Market Size by Type (2023-2028)

5 Next-Generation Sequencing (NGS) Services Breakdown Data by Application

5.1 Global Next-Generation Sequencing (NGS) Services Historic Market Size by Application (2017-2022)

5.2 Global Next-Generation Sequencing (NGS) Services Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Next-Generation Sequencing (NGS) Services Market Size (2017-2028)

6.2 North America Next-Generation Sequencing (NGS) Services Market Size by Country (2017-2022)

6.3 North America Next-Generation Sequencing (NGS) Services Market Size by Country (2023-2028)

6.4 United States

6.5 Canada

7 Europe

7.1 Europe Next-Generation Sequencing (NGS) Services Market Size (2017-2028)

7.2 Europe Next-Generation Sequencing (NGS) Services Market Size by Country (2017-2022)

7.3 Europe Next-Generation Sequencing (NGS) Services Market Size by Country (2023-2028)

7.4 Germany

7.5 France

7.6 U.K.

7.7 Italy

7.8 Russia

7.9 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size (2017-2028)

8.2 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size by Country (2017-2022)

8.3 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size by Country (2023-2028)

8.4 China

8.5 Japan

8.6 South Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9 Latin America

9.1 Latin America Next-Generation Sequencing (NGS) Services Market Size (2017-2028)

9.2 Latin America Next-Generation Sequencing (NGS) Services Market Size by Country (2017-2022)

9.3 Latin America Next-Generation Sequencing (NGS) Services Market Size by Country (2023-2028)

9.4 Mexico

9.5 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size (2017-2028)

10.2 Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size by Country (2017-2022)

10.3 Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size by Country (2023-2028)

10.4 Turkey

10.5 Saudi Arabia

10.6 UAE

11 Key Players Profiles

11.1 Eurofins Scientific

11.1.1 Eurofins Scientific Company Detail

11.1.2 Eurofins Scientific Business Overview

11.1.3 Eurofins Scientific Next-Generation Sequencing (NGS) Services Introduction

11.1.4 Eurofins Scientific Revenue in Next-Generation Sequencing (NGS) Services Business (2017-2022)

11.1.5 Eurofins Scientific Recent Development

11.2 Natera

11.2.1 Natera Company Detail

11.2.2 Natera Business Overview

11.2.3 Natera Next-Generation Sequencing (NGS) Services Introduction

11.2.4 Natera Revenue in Next-Generation Sequencing (NGS) Services Business (2017-2022)

11.2.5 Natera Recent Development

11.3 BGI

11.3.1 BGI Company Detail

11.3.2 BGI Business Overview

11.3.3 BGI Next-Generation Sequencing (NGS) Services Introduction

11.3.4 BGI Revenue in Next-Generation Sequencing (NGS) Services Business (2017-2022)

11.3.5 BGI Recent Development

11.4 Illumina

11.4.1 Illumina Company Detail

11.4.2 Illumina Business Overview

11.4.3 Illumina Next-Generation Sequencing (NGS) Services Introduction

11.4.4 Illumina Revenue in Next-Generation Sequencing (NGS) Services Business (2017-2022)

11.4.5 Illumina Recent Development

11.5 Roche

11.5.1 Roche Company Detail

11.5.2 Roche Business Overview

11.5.3 Roche Next-Generation Sequencing (NGS) Services Introduction

11.5.4 Roche Revenue in Next-Generation Sequencing (NGS) Services Business (2017-2022)

11.5.5 Roche Recent Development

11.6 LabCorp

11.6.1 LabCorp Company Detail

11.6.2 LabCorp Business Overview

11.6.3 LabCorp Next-Generation Sequencing (NGS) Services Introduction

11.6.4 LabCorp Revenue in Next-Generation Sequencing (NGS) Services Business (2017-2022)

11.6.5 LabCorp Recent Development

11.7 Berry Genomics

11.7.1 Berry Genomics Company Detail

11.7.2 Berry Genomics Business Overview

11.7.3 Berry Genomics Next-Generation Sequencing (NGS) Services Introduction

11.7.4 Berry Genomics Revenue in Next-Generation Sequencing (NGS) Services Business (2017-2022)

11.7.5 Berry Genomics Recent Development

11.8 Brooks Life Sciences

11.8.1 Brooks Life Sciences Company Detail

11.8.2 Brooks Life Sciences Business Overview

11.8.3 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Introduction

11.8.4 Brooks Life Sciences Revenue in Next-Generation Sequencing (NGS) Services Business (2017-2022)

11.8.5 Brooks Life Sciences Recent Development

11.9 Macrogen

11.9.1 Macrogen Company Detail

11.9.2 Macrogen Business Overview

11.9.3 Macrogen Next-Generation Sequencing (NGS) Services Introduction

11.9.4 Macrogen Revenue in Next-Generation Sequencing (NGS) Services Business (2017-2022)

11.9.5 Macrogen Recent Development

11.10 Personalis

11.10.1 Personalis Company Detail

11.10.2 Personalis Business Overview

11.10.3 Personalis Next-Generation Sequencing (NGS) Services Introduction

11.10.4 Personalis Revenue in Next-Generation Sequencing (NGS) Services Business (2017-2022)

11.10.5 Personalis Recent Development

11.11 Novogene

11.11.1 Novogene Company Detail

11.11.2 Novogene Business Overview

11.11.3 Novogene Next-Generation Sequencing (NGS) Services Introduction

11.11.4 Novogene Revenue in Next-Generation Sequencing (NGS) Services Business (2017-2022)

11.11.5 Novogene Recent Development

11.12 Genotypic Technology

11.12.1 Genotypic Technology Company Detail

11.12.2 Genotypic Technology Business Overview

11.12.3 Genotypic Technology Next-Generation Sequencing (NGS) Services Introduction

11.12.4 Genotypic Technology Revenue in Next-Generation Sequencing (NGS) Services Business (2017-2022)

11.12.5 Genotypic Technology Recent Development

11.13 Dna Link

11.13.1 Dna Link Company Detail

11.13.2 Dna Link Business Overview

11.13.3 Dna Link Next-Generation Sequencing (NGS) Services Introduction

11.13.4 Dna Link Revenue in Next-Generation Sequencing (NGS) Services Business (2017-2022)

11.13.5 Dna Link Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

Choose License Type

Checkout Inquiry Sample